---
title: "12 Health Care Stocks Moving In Tuesday's Intraday Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293370789.md"
description: "During Tuesday's intraday session, several healthcare stocks experienced significant volatility. China Pharma Holding surged 713.2% to $7.4, while Wellgistics Health rose 27.3%. Other gainers included Greenland Mines, Dyadic International, Telomir Pharmaceuticals, and Femasys. Conversely, Zhengye Biotechnology plummeted 67.2% to $2.63, with Lisata Therapeutics, PolyPid, Advanced Biomed, GlucoTrack, and Niki BioSolutions also posting notable declines."
datetime: "2026-07-21T17:05:34.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293370789.md)
  - [en](https://longbridge.com/en/news/293370789.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293370789.md)
---

# 12 Health Care Stocks Moving In Tuesday's Intraday Session

### Gainers

-   **China Pharma Holding** (AMEX:CPHI) shares increased by 713.2% to $7.4 during Tuesday's regular session. The company's market cap stands at $36.8 million.
-   **Wellgistics Health** (NASDAQ:WGRX) shares increased by 27.3% to $3.45. The company's market cap stands at $6.8 million.
-   **Greenland Mines** (NASDAQ:GRML) stock increased by 27.11% to $0.24. The company's market cap stands at $28.0 million.
-   **Dyadic International** (NASDAQ:DYAI) shares rose 23.14% to $1.49. The company's market cap stands at $44.0 million.
-   **Telomir Pharmaceuticals** (NASDAQ:TELO) stock rose 21.84% to $1.12. The market value of their outstanding shares is at $63.2 million.
-   **Femasys** (NASDAQ:FEMY) stock increased by 19.87% to $3.92. The market value of their outstanding shares is at $9.8 million.

### Losers

-   **Zhengye Biotechnology** (NASDAQ:ZYBT) stock fell 67.2% to $2.63 during Tuesday's regular session. The company's market cap stands at $379.6 million.
-   **Lisata Therapeutics** (NASDAQ:LSTA) shares fell 39.64% to $2.13. The market value of their outstanding shares is at $32.1 million.
-   **PolyPid** (NASDAQ:PYPD) stock fell 21.36% to $4.05. The company's market cap stands at $52.4 million.
-   **Advanced Biomed** (NASDAQ:ADVB) stock fell 21.02% to $7.03. The company's market cap stands at $14.5 million.
-   **GlucoTrack** (NASDAQ:GCTK) shares fell 16.83% to $0.34. The market value of their outstanding shares is at $2.6 million.
-   **Niki BioSolutions** (NASDAQ:NIKI) shares declined by 14.61% to $7.54. The market value of their outstanding shares is at $71.9 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [TELO.US](https://longbridge.com/en/quote/TELO.US.md)
- [CPHI.US](https://longbridge.com/en/quote/CPHI.US.md)
- [NIKI.US](https://longbridge.com/en/quote/NIKI.US.md)
- [FEMY.US](https://longbridge.com/en/quote/FEMY.US.md)
- [ZYBT.US](https://longbridge.com/en/quote/ZYBT.US.md)
- [GCTK.US](https://longbridge.com/en/quote/GCTK.US.md)
- [LSTA.US](https://longbridge.com/en/quote/LSTA.US.md)
- [GRML.US](https://longbridge.com/en/quote/GRML.US.md)
- [DYAI.US](https://longbridge.com/en/quote/DYAI.US.md)
- [ADVB.US](https://longbridge.com/en/quote/ADVB.US.md)
- [PYPD.US](https://longbridge.com/en/quote/PYPD.US.md)
- [WGRX.US](https://longbridge.com/en/quote/WGRX.US.md)
- [MEDS.US](https://longbridge.com/en/quote/MEDS.US.md)
- [GRMLW.US](https://longbridge.com/en/quote/GRMLW.US.md)

## Related News & Research

- [Lisata Therapeutics Terminates Kuva Labs Merger After Financing Failure; To Receive $2 Million Fee](https://longbridge.com/en/news/293779896.md)
- [DataMEDS AI Officially Begins Trading Under Stock Symbol 'MEDS' on the NASDAQ Capital Markets | MEDS Stock News](https://longbridge.com/en/news/293472382.md)
- [China Pharma Holdings Announces New Capital Raising Agreement](https://longbridge.com/en/news/293531766.md)
- [PolyPid says FDA accepts D-PLEX100 NDA, grants priority review](https://longbridge.com/en/news/294208202.md)
- [PolyPid Locks in a Transformative Deal Worth Over $320 Million, With Additional Major Royalty Potential](https://longbridge.com/en/news/293345524.md)